Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions
Kathrin Thiem(Radboud University Nijmegen), Janna A. van Diepen(Reckitt Benckiser (Netherlands)), Geerte Hoeke(Leiden University Medical Center), Johan Bussink(Radboud University Nijmegen), Mihai G. Netea(Radboud University Nijmegen), Enchen Zhou(University of California San Diego), Patrick C.N. Rensen(Leiden University Medical Center), Jimmy F.P. Berbée(Leiden University Medical Center), Margien G. S. Boels(Leiden University Medical Center), Mariëtte R. Boon(Leiden University Medical Center), Esther Lutgens(Mayo Clinic), Thirumala‐Devi Kanneganti(St. Jude Children's Research Hospital), Anneke Hijmans(Radboud University Nijmegen), Ronit Shiri‐Sverdlov(Maastricht University), Tom Houben(Maastricht University), Rinke Stienstra(Radboud University Nijmegen), Isabel M. Mol(Leiden University Medical Center), Cees J. Tack(Radboud University Nijmegen)
Cited by 10
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k